This article describes the pathophysiology and potential treatments for Gulf War Illness
(GWI), which is a chronic neuropsychiatric illness linked to a combination of chemical …

Contrary to the optimistic expectations three decades ago, global military expenditure is
increasing rather rapidly, fueled by the increasing intensity of international tensions. As a …

Chemical and pharmaceutical exposures have been associated with the development of
Gulf War Illness (GWI), but how these factors interact with the pathophysiology of traumatic …

Approximately one-third of Gulf War veterans suffer from Gulf War Illness (GWI), which
encompasses mood disorders and depressive symptoms. Deployment-related exposure to …

Organophosphate (OP) chemicals include commonly used pesticides and chemical warfare
agents, and mechanistically they are potent inhibitors of the cholinesterase (ChE) enzyme …

Both the epigenetic changes and gut microbiota (GM) have attracted a growing interest in
establishing effective diagnostics and potential therapeutic strategies for a number of …

Though it has been over 30 years since the 1990–1991 Gulf War (GW), the pathophysiology
of Gulf War Illness (GWI), the complex, progressive illness affecting approximately 30% of …

Gulf War illness (GWI) is a chronic multifaceted condition with debilitating pain and fatigue,
as well as sleep, behavioral, and cognitive impairments in war veterans. Currently, there is …

Unraveling the multisymptomatic Gulf War Illness (GWI) pathology and finding an effective
cure have eluded researchers for decades. The chronic symptom persistence and limitations …

Operations Desert Shield and Storm occurred over 30 years ago, yet many of those who
were deployed continue to experience chronic and debilitating symptoms, now recognized …